Sidoti Estimates Hawkins' Q4 Earnings (NASDAQ:HWKN)

Key Points

• Sidoti cut Hawkins’ Q4 2028 EPS estimate to $1.02 from $1.25, while the full-year consensus estimate stands at $4.04 per share.
• Hawkins’ latest quarterly EPS of $1.35 missed estimates of $1.39, although revenue of $315.68 million exceeded expectations of $313.42 million.
• Analyst sentiment is mixed, with a consensus “Hold” rating and a $171 target price. Hawkins also declared a $0.19 quarterly dividend, equating to a 0.6% annualized yield.

Hawkins, Inc. (NASDAQ:HWKN - Free Report) - Investment analysts at Sidoti reduced their Q4 2028 earnings estimates for Hawkins in a research report issued to clients and investors on Tuesday, August 4th. Sidoti analyst D. Harriman now expects that the specialty chemicals company will post earnings per share of $1.02 for the quarter, down from their prior estimate of $1.25. The consensus estimate for Hawkins' current full-year earnings is $4.04 per share.

Hawkins (NASDAQ:HWKN - Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The specialty chemicals company reported $1.35 earnings per share for the quarter, missing the consensus estimate of $1.39 by ($0.04). Hawkins had a return on equity of 15.42% and a net margin of 7.29%.The business had revenue of $315.68 million for the quarter, compared to analysts' expectations of $313.42 million.

Several other equities analysts also recently weighed in on HWKN. Zacks Research downgraded shares of Hawkins from a "hold" rating to a "strong sell" rating in a report on Tuesday. BWS Financial restated a "buy" rating and set a $200.00 price objective on shares of Hawkins in a research report on Monday. Barclays set a $142.00 target price on shares of Hawkins and gave the company an "equal weight" rating in a research note on Friday, July 31st. Finally, Weiss Ratings downgraded shares of Hawkins from a "buy (b-)" rating to a "hold (c+)" rating in a report on Tuesday, July 14th. One research analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $171.00.

Hawkins Stock Up 1.2%

NASDAQ HWKN opened at $135.29 on Thursday. Hawkins has a 52 week low of $117.98 and a 52 week high of $186.15. The company has a quick ratio of 1.54, a current ratio of 2.27 and a debt-to-equity ratio of 0.45. The company has a market capitalization of $2.82 billion, a P/E ratio of 35.05, a price-to-earnings-growth ratio of 2.54 and a beta of 0.79. The stock's 50-day moving average price is $147.18 and its 200-day moving average price is $149.48.

Hawkins Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 28th. Shareholders of record on Friday, August 14th will be issued a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Friday, August 14th. Hawkins's dividend payout ratio (DPR) is 20.73%.

Hedge Funds Weigh In On Hawkins

Several hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. increased its holdings in Hawkins by 1.4% in the 4th quarter. Vanguard Group Inc. now owns 1,525,789 shares of the specialty chemicals company's stock valued at $216,754,000 after acquiring an additional 20,958 shares during the last quarter. State Street Corp boosted its holdings in shares of Hawkins by 11.6% during the 4th quarter. State Street Corp now owns 1,067,451 shares of the specialty chemicals company's stock valued at $151,642,000 after purchasing an additional 111,318 shares during the last quarter. Wasatch Advisors LP boosted its holdings in shares of Hawkins by 31.4% during the 4th quarter. Wasatch Advisors LP now owns 552,419 shares of the specialty chemicals company's stock valued at $78,477,000 after purchasing an additional 131,850 shares during the last quarter. Geode Capital Management LLC grew its position in shares of Hawkins by 2.8% during the fourth quarter. Geode Capital Management LLC now owns 513,535 shares of the specialty chemicals company's stock valued at $72,965,000 after purchasing an additional 13,828 shares in the last quarter. Finally, Capital World Investors grew its position in shares of Hawkins by 34.4% during the fourth quarter. Capital World Investors now owns 477,985 shares of the specialty chemicals company's stock valued at $67,903,000 after purchasing an additional 122,366 shares in the last quarter. Hedge funds and other institutional investors own 69.71% of the company's stock.

More Hawkins News

Here are the key news stories impacting Hawkins this week:

• Positive Sentiment: Sidoti raised its Q2 2027 EPS estimate to $1.26 from $1.25, and increased its Q1 2028 forecast to $1.57 from $1.55. The firm also lifted its Q2 2028 estimate to $1.48 from $1.45.
• Neutral Sentiment: Sidoti currently projects FY2027 EPS of $4.20 and FY2028 EPS of $5.00. These forecasts provide a benchmark for future performance, but the estimates remain subject to changes in specialty-chemical demand, pricing and operating costs.
• Negative Sentiment: Sidoti cut its FY2027 EPS estimate to $4.20 from $4.45 and reduced its FY2028 forecast to $5.00 from $5.35. The firm also lowered estimates for Q3 2027 to $0.76 from $0.90, Q4 2027 to $0.82 from $0.95, Q3 2028 to $0.93 from $1.10 and Q4 2028 to $1.02 from $1.25.
• Negative Sentiment: The revisions follow Hawkins’ latest quarterly report, in which EPS of $1.35 missed the $1.39 consensus estimate, although revenue exceeded expectations. With the stock trading below its 50-day and 200-day moving averages and carrying a relatively elevated P/E ratio near 35, downward earnings revisions could limit enthusiasm despite the modest positive quarterly changes.

About Hawkins

Hawkins, Inc NASDAQ: HWKN is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins' product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source